Jade Biosciences, Inc
Price
FilingsNewest: 8-K, Other eventsSep 30 →InsidersNo open-market buys or sales.→HoldersFMR 14.4%Jupiter Topco 9.9%Fairmount Funds 7.2%→Financing →PeersClosest companies: DMRA, APGE, SYRE→
From the filings
Figures
- Net income
- −$153.2Mlast 12 months
- Operating cash flow
- −$100.0Mlast 12 months
- Cash and equivalents
- $107.3Mat the last balance sheet
- Shares outstanding
- 63.6M shareson issue